D-Erythroascorbic acid 1'-a-D-xylopyranoside

Metabolite details

Identifier

CMPVKMSVRPPYHP-UHFFFAOYSA-N

InChI Key

CMPVKMSVRPPYHP-UHFFFAOYSA-N

IUPAC name

3,4-dihydroxy-2-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]-2H-uran-5-one

Preferred name

D-Erythroascorbic acid 1'-a-D-xylopyranoside

INN name

—

Synonym

—

ChEBI

CHEBI:191458

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase the Trimethoprim Resistance in Aeromonas veronii
• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Transcriptome and Metabolome Analyses Reveal Differences in Terpenoid and Flavonoid Biosynthesis in Cryptomeria fortunei Needles Across Different Seasons
• Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis

Observed in differential profiles

• Wild_type_vs_hfq
• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• Control_vs_nsPEF_7_day
• Summer_vs_Winter
• Control_vs_CSD
• Control_vs_ZYP_High_Dose